Indonesia is currently facing a critical public health turning point as the national social security agency, BPJS Kesehatan, issues a stern warning regarding the exponential rise in kidney failure cases across the archipelago. According to recent data released by the agency, the financial burden for treating renal failure is projected to skyrocket by 400 percent by 2025, reaching a staggering IDR 13.38 trillion. This figure represents a massive leap from the IDR 2.32 trillion recorded in 2019, highlighting a deteriorating trend in national health that threatens to strain the country’s healthcare infrastructure and fiscal stability.
The alarming trajectory of kidney-related ailments in Indonesia mirrors a broader regional crisis. Neighboring Malaysia has reported similar challenges, currently spending approximately RM 3.3 billion, or roughly IDR 14.22 trillion, annually on treatments for end-stage renal disease. However, the pace of the increase in Indonesia has caught health officials off guard, as kidney failure has rapidly climbed the ranks of the most expensive catastrophic diseases covered by the National Health Insurance (JKN) program.
A Drastic Shift in Disease Prevalence and Financing
To understand the scale of the crisis, one must look at the shifting landscape of disease statistics provided by BPJS Kesehatan between 2024 and 2025. In 2024, kidney failure was ranked as the fourth most expensive ailment to treat. During that year, heart disease led the list with 22.55 million cases and a total cost of IDR 19.25 trillion. It was followed by cancer, which saw 4.24 million cases costing IDR 6.48 trillion, and stroke, with 3.89 million cases and a budget of IDR 5.81 trillion. At that time, kidney failure accounted for 1.44 million cases with a total expenditure of IDR 2.76 trillion.
However, data for 2025 indicates a radical and concerning transformation. While heart disease remains the primary drain on the national health budget—reaching 29.73 million cases with a cost of IDR 17 trillion—kidney failure has surged past both cancer and stroke to claim the second position. The number of kidney failure cases is projected to explode to 12.68 million, with the associated costs swelling to IDR 13.38 trillion. In comparison, cancer has moved to third place with 7.19 million cases costing IDR 10.3 trillion, while stroke cases have risen to 9.53 million with a cost of IDR 7.2 trillion.
The nearly tenfold increase in reported kidney failure cases within a single year suggests not only a rise in actual illness but also an improvement in diagnostic reach and a higher volume of patients seeking long-term maintenance treatments, such as hemodialysis.
The Medical Catalyst: Hypertension and Diabetes
The Director of BPJS Kesehatan, Prihati Pujowaskito, has identified the primary drivers behind this "silent epidemic." The surge is not an isolated phenomenon but rather a direct consequence of the uncontrolled prevalence of hypertension and diabetes mellitus among the Indonesian population. These two conditions are the leading precursors to chronic kidney disease (CKD), eventually leading to total kidney failure if left unmanaged.
"Our primary concern lies in diabetes mellitus and hypertension," Prihati stated during a recent briefing. "These are the conditions we must aggressively target through promotional and preventive approaches. By managing these underlying issues, we can significantly reduce the long-term financial burden on our national health system."
Medical experts explain that chronic hypertension damages the blood vessels throughout the body, including those in the kidneys, reducing their ability to filter waste and extra fluid from the blood. Similarly, high blood sugar levels associated with diabetes can overwork the kidneys’ filtering system, eventually leading to permanent scarring and loss of function. Because these conditions often present no symptoms in their early stages, many patients only seek medical attention when their kidney function has already declined by 80 to 90 percent.
The Reality of Hemodialysis and Patient Quality of Life
Siti Nadia Tarmizi, Director of Non-Communicable Diseases at the Ministry of Health, corroborated the BPJS findings, emphasizing the severe impact kidney failure has on both the individual and the state. Patients diagnosed with end-stage renal disease (ESRD) typically require hemodialysis, commonly known as "cuci darah," to survive.
Hemodialysis is a life-sustaining procedure that uses a machine to filter toxins, such as urea and creatinine, and excess fluids from the blood—a task the kidneys can no longer perform. For most patients, this requires visiting a hospital or dialysis center two to three times a week for sessions that last four to five hours each. While the procedure is essential for preventing lethal complications and maintaining electrolyte balance, it is also one of the most expensive recurring treatments in modern medicine.
"Kidney failure is a silent killer," Nadia warned. "It often begins with uncontrolled high blood pressure or sugar levels. The fact that it has shown the highest increase in financing compared to other diseases is a clear indicator that the number of cases is burgeoning. We must urge the public to be more vigilant about their intake of sugar, salt, and fat."
Preventive Measures and the "Nutri Level" Initiative
In response to the escalating crisis, the Indonesian government is shifting its healthcare strategy from a curative-heavy model to one focused on prevention and promotion. The high cost of treating millions of patients for kidney failure is viewed as unsustainable for the BPJS Kesehatan fund in the long run.
One of the flagship initiatives recently introduced is the "Nutri Level" labeling system for ready-to-eat and processed foods. Similar to systems used in Singapore and other developed nations, Nutri Level provides clear visual indicators of the nutritional quality of food products, specifically highlighting levels of sugar, salt, and fat. By educating consumers at the point of purchase, the Ministry of Health hopes to curb the rising rates of obesity and diabetes that fuel the kidney failure crisis.
Furthermore, BPJS Kesehatan is intensifying its screening programs. Early detection of hypertension and diabetes allows for early intervention with medication and lifestyle changes, which can delay or even prevent the progression to kidney failure. This "upstream" approach is seen as the only viable way to protect the national budget while improving the life expectancy of the population.
Economic Implications and the Path Forward
The economic impact of the kidney failure surge extends beyond the direct costs of medical treatment. Chronic kidney disease predominantly affects the productive-age population, leading to a loss of workforce productivity. Patients undergoing regular dialysis often find it difficult to maintain full-time employment, and the psychological and financial toll on their families is immense.
The 400 percent increase in financing also places significant pressure on the government to re-evaluate its health budget allocations. With IDR 13.38 trillion earmarked for a single disease category, there are growing calls for the implementation of a sugar-sweetened beverage (SSB) tax. Proponents argue that such a tax would provide a dual benefit: generating revenue to fund the JKN program while simultaneously discouraging the consumption of high-sugar drinks that contribute to the diabetes epidemic.
As 2025 approaches, the focus of the Ministry of Health and BPJS Kesehatan remains fixed on behavioral change. Public health campaigns are increasingly targeting younger demographics, emphasizing that the lifestyle choices made today—such as excessive consumption of "kekinian" (trendy) high-sugar drinks and processed snacks—will dictate the health of the nation’s kidneys a decade from now.
The warning from BPJS Kesehatan serves as a wake-up call for all sectors of society. Without a collective shift toward healthier living and more robust preventive healthcare, the "meroket" or skyrocketing trend of kidney failure could become a permanent and paralyzing feature of the Indonesian healthcare landscape. The transition toward a more sustainable health system will require not just government intervention through initiatives like Nutri Level, but a fundamental change in how the Indonesian public views and manages chronic health risks.
